PMID: 36877283

Elacestrant (Orserdu) for advanced or metastatic breast cancer.

The Medical letter on drugs and therapeutics · 2023

Vol. 65, Issue 1671, pp. 38-40

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansFemaleBreast NeoplasmsTetrahydronaphthalenes

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.